David G. Brooks

13.7k total citations · 4 hit papers
120 papers, 8.4k citations indexed

About

David G. Brooks is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, David G. Brooks has authored 120 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Immunology, 30 papers in Molecular Biology and 28 papers in Epidemiology. Recurrent topics in David G. Brooks's work include Immune Cell Function and Interaction (51 papers), T-cell and B-cell Immunology (30 papers) and Immunotherapy and Immune Responses (16 papers). David G. Brooks is often cited by papers focused on Immune Cell Function and Interaction (51 papers), T-cell and B-cell Immunology (30 papers) and Immunotherapy and Immune Responses (16 papers). David G. Brooks collaborates with scholars based in United States, Canada and United Kingdom. David G. Brooks's co-authors include Heidi Elsaesser, Michael B. A. Oldstone, Dorian B. McGavern, Elizabeth Wilson, Laura M. Snell, Jerome A. Zack, Luc Teyton, Karsten Sauer, Tracy L. McGaha and Kurt H. Edelmann and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

David G. Brooks

118 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-10 determines viral clearance or persistence in vivo

2006 755 citations David G. Brooks, Luc Teyton et al. Nature Medicine profile →
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

2013 548 citations Elizabeth Wilson, Douglas H. Yamada et al. Science profile →
Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity

2013 419 citations Heidi Elsaesser, Elizabeth Wilson et al. Nature Immunology profile →
Type I Interferon in Chronic Virus Infection and Cancer

2017 336 citations Laura M. Snell, Tracy L. McGaha et al. profile →

Peers

Countries citing papers authored by David G. Brooks

Since Specialization

Citations

This map shows the geographic impact of David G. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Brooks more than expected).

Fields of papers citing papers by David G. Brooks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Brooks. The network helps show where David G. Brooks may publish in the future.

Co-authorship network of co-authors of David G. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Brooks. A scholar is included among the top collaborators of David G. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Brooks. David G. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Presentation of immunoregulatory sialoglycans on T cells is divergent between mice and humans 2025 ·Cell Reports ·(unknown), (unknown), (unknown), Diala Abd-Rabbo, Heidi Elsaesser, (unknown), (unknown), Vinicius Kannen, (unknown), Edward N. Schmidt, (unknown), (unknown), (unknown), (unknown), Haissi Cui, Jason Matthews, Thierry Mallevaey, Matthew S. Macauley, David G. Brooks, Landon J. Edgar	2
2	IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B 2023 ·Hepatology Communications ·(unknown), Loghman Salimzadeh, Ann T., Oyedele Adeyi, (unknown), Giselle M. Boukhaled, (unknown), Anjali Patel, Sara Ferrando‐Martínez, Scott H. Robbins, (unknown), David Wong, Harry L.A. Janssen, David G. Brooks, Jordan J. Feld, Adam J. Gehring	8
3	The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity 2022 ·Immunity ·Sabelo Lukhele, (unknown), Mengdi Guo, Jian Shen, Heidi Elsaesser, Rene Quevedo, (unknown), Ramy Gadalla, Laura M. Snell, (unknown), Marion Ciudad, Bryan E. Snow, Annick You-Ten, Jillian Haight, Andrew Wakeham, Pamela S. Ohashi, Tak W. Mak, Weiguo Cui, Tracy L. McGaha, David G. Brooks	67
4	Prevention of CD8 T Cell Deletion during Chronic Viral Infection 2021 ·Viruses ·David G. Brooks, Antoinette Tishon, Michael B. A. Oldstone, Dorian B. McGavern	6
5	Dynamic CD4+ T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection 2021 ·Nature Immunology ·Laura M. Snell, Wenxi Xu, Diala Abd-Rabbo, Giselle M. Boukhaled, Mengdi Guo, Bethany MacLeod, Heidi Elsaesser, Kebria Hezaveh, Nirmin Alsahafi, Sabelo Lukhele, Sara Nejat, (unknown), Slava Epelman, Tracy L. McGaha, David G. Brooks	28
6	A network of immune and microbial modifications underlies viral persistence in the gastrointestinal tract 2020 ·The Journal of Experimental Medicine ·Bethany MacLeod, Heidi Elsaesser, Laura M. Snell, Russell J. Dickson, Mengdi Guo, Kebria Hezaveh, Wenxi Xu, Akash Kothari, Tracy L. McGaha, Cynthia J. Guidos, David G. Brooks	8
7	Staphylococcus capitis Osteomyelitis: Case Report 2019 ·Global Pediatric Health ·David G. Brooks, Vincent C. Thomas, Jessica Snowden	7
8	CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses 2018 ·The Journal of Immunology ·Jin Seok Woo, Sonal Srikanth, Kyun‐Do Kim, Heidi Elsaesser, Jing Lü, Matteo Pellegrini, David G. Brooks, Zuoming Sun, Yousang Gwack	17
9	Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming 2017 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), (unknown), Yoshiko Nagaoka, (unknown), Jing Wen, Heidi Elsaesser, Meng Qin, David G. Brooks, Gene-Errol Ringpis, Irvin S. Y. Chen, Masakazu Kamata	1
10	Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection breakdown → 2013 ·Science ·Elizabeth Wilson, Douglas H. Yamada, Heidi Elsaesser, Jonathan Herskovitz, Jane C. Deng, Genhong Cheng, Bruce J. Aronow, Christopher L. Karp, David G. Brooks	548
11	Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses 2013 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Kavitha Balaji, Daniel L. Clemens, Gang Deng, Yao E. Wang, Heidi Elsaesser, Batcha Tamilselvam, (unknown), (unknown), Bryan France, Brian T. Chamberlain, Steven R. Blanke, Genhong Cheng, Juan Carlos de la Torre, David G. Brooks, Michael E. Jung, John Colicelli, Robert Damoiseaux, Kenneth A. Bradley	71
12	Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells 2011 ·The Journal of Experimental Medicine ·Laura Fahey, Elizabeth Wilson, Heidi Elsaesser, (unknown), Dorian B. McGavern, David G. Brooks	260
13	The Role of IL-10 in Regulating Immunity to Persistent Viral Infections 2010 ·Current topics in microbiology and immunology ·Elizabeth Wilson, David G. Brooks	136
14	IL-21 Is Required to Control Chronic Viral Infection 2009 ·Science ·Heidi Elsaesser, Karsten Sauer, David G. Brooks	445
15	Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II 2007 ·Virology ·Dirk Homann, Hanna Lewicki, David G. Brooks, Jens Eberlein, Valérie Mallet-Designe, Luc Teyton, Michael B. A. Oldstone	30
16	Decreased Serum Ferritin is Associated With Alopecia in Women 2003 ·Journal of Investigative Dermatology ·Jonathan Kantor, Lisa Kessler, David G. Brooks, George Cotsarelis	156
17	Lens changes in hereditary hyperferritinemia-cataract syndrome 2001 ·American Journal of Ophthalmology ·(unknown), Steven Ades, David P. Schenkein, David G. Brooks, Dwight Stambolian, Michael B. Raizman	20
18	In vivo evidence of brain galactitol accumulation in an infant with galactosemia and encephalopathy 2001 ·The Journal of Pediatrics ·Gerard T. Berry, Jill V. Hunter, Zhiyue Wang, (unknown), Alice Mazur, David G. Brooks, Ning Cong, Robert A. Zimmerman, Stanton Segal	47
19	Generation of HIV latency during thymopoiesis 2001 ·Nature Medicine ·David G. Brooks, Scott G. Kitchen, Christina M. Ramirez, Deirdre D. Scripture-Adams, Jerome A. Zack	145
20	Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. 1989 ·The Journal of Experimental Medicine ·David G. Brooks, Wei Qiao Qiu, Andrew D. Luster, Jeffrey V. Ravetch	268

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact